Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Common Equity (2016 - 2025)

Historic Common Equity for Bioceres Crop Solutions (BIOX) over the last 10 years, with Q3 2025 value amounting to $258.7 million.

  • Bioceres Crop Solutions' Common Equity fell 1641.92% to $258.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $258.7 million, marking a year-over-year decrease of 1641.92%. This contributed to the annual value of $265.4 million for FY2025, which is 2445.67% down from last year.
  • Latest data reveals that Bioceres Crop Solutions reported Common Equity of $258.7 million as of Q3 2025, which was down 1641.92% from $265.4 million recorded in Q2 2025.
  • Bioceres Crop Solutions' Common Equity's 5-year high stood at $387.0 million during Q4 2021, with a 5-year trough of $61.0 million in Q1 2021.
  • Moreover, its 5-year median value for Common Equity was $299.0 million (2023), whereas its average is $250.5 million.
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 53169.33% in 2021, then tumbled by 2956.49% in 2022.
  • Quarter analysis of 5 years shows Bioceres Crop Solutions' Common Equity stood at $387.0 million in 2021, then dropped by 29.56% to $272.6 million in 2022, then grew by 10.25% to $300.5 million in 2023, then increased by 3.0% to $309.6 million in 2024, then decreased by 16.44% to $258.7 million in 2025.
  • Its Common Equity was $258.7 million in Q3 2025, compared to $265.4 million in Q2 2025 and $308.5 million in Q1 2025.